Lufax (NYSE: LU) CEO Cho Yong Suk reports options over 500,000 shares
Filing Impact
Filing Sentiment
Form Type
3
Rhea-AI Filing Summary
Lufax Holding Ltd director and Chief Executive Officer Cho Yong Suk filed an initial ownership report showing existing stock option holdings. He holds stock options to buy 100,000 Ordinary Shares at an exercise price of 15.14 expiring on April 8, 2026, and additional options to buy 400,000 Ordinary Shares at an exercise price of 18.06 expiring on December 29, 2027, all held directly.
Positive
- None.
Negative
- None.
Insider Trade Summary
2 transactions reported
Mixed
2 txns
Insider
Cho Yong Suk
Role
Chief Executive Officer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Stock Options (right to buy) | -- | -- | -- |
| holding | Stock Options (right to buy) | -- | -- | -- |
Holdings After Transaction:
Stock Options (right to buy) — 100,000 shares (Direct)
Footnotes (1)
FAQ
What does the Lufax (LU) Form 3 filing by CEO Cho Yong Suk show?
The Form 3 shows CEO and director Cho Yong Suk’s existing stock option holdings in Lufax Holding Ltd. It lists two option grants over Ordinary Shares, including exercise prices, share amounts, expiration dates, and that the positions are held directly rather than through another entity.
What are the exercise prices and expiration dates of Lufax CEO Cho Yong Suk’s options?
One option grant allows purchase of 100,000 Ordinary Shares at 15.14, expiring on April 8, 2026. A second grant covers 400,000 Ordinary Shares at 18.06, expiring on December 29, 2027. Both positions are reported in the Form 3 as directly held.
Is Lufax (LU) CEO Cho Yong Suk buying or selling stock in this Form 3?
The Form 3 does not report new purchases or sales; it records existing holdings. It lists two stock option awards over Lufax Ordinary Shares as of the reporting date, classifying them as holdings rather than new transactions or open-market trades.
What type of securities are disclosed in Lufax (LU) CEO Cho Yong Suk’s Form 3?
The filing discloses derivative securities described as “Stock Options (right to buy).” Each option is linked to Lufax Ordinary Shares, with underlying amounts of 100,000 and 400,000 shares respectively, along with their specific exercise prices and expiration dates.